BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8774190)

  • 1. Improvement of severe pulmonary hypertension in a patient with SLE.
    Karmochkine M; Wechsler B; Godeau P; Brenot F; Jagot JL; Simonneau G
    Ann Rheum Dis; 1996 Aug; 55(8):561-2. PubMed ID: 8774190
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful treatment with immunosuppression, anticoagulation and vasodilator therapy of pulmonary hypertension in SLE associated with secondary antiphospholipid syndrome.
    Tam LS; Li EK
    Lupus; 1998; 7(7):495-7. PubMed ID: 9796854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is sildenafil effective in secondary pulmonary hypertension due to systemic lupus erythematosus? A case report.
    Hanta I; Demir M; Akpinar O; Kocabas A; Ozbek S
    Clin Rheumatol; 2005 Nov; 24(6):671-2. PubMed ID: 15951919
    [No Abstract]   [Full Text] [Related]  

  • 4. Pulmonary arterial hypertension in systemic lupus erythematosus may benefit by addition of immunosuppression to vasodilator therapy: an observational study.
    Kommireddy S; Bhyravavajhala S; Kurimeti K; Chennareddy S; Kanchinadham S; Rajendra Vara Prasad I; Rajasekhar L
    Rheumatology (Oxford); 2015 Sep; 54(9):1673-9. PubMed ID: 25929760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary arterial hypertension responsive to immunosuppressive therapy in systemic lupus erythematosus.
    Morelli S; Giordano M; De Marzio P; Priori R; Sgreccia A; Valesini G
    Lupus; 1993 Dec; 2(6):367-9. PubMed ID: 8136819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases.
    Jais X; Launay D; Yaici A; Le Pavec J; Tchérakian C; Sitbon O; Simonneau G; Humbert M
    Arthritis Rheum; 2008 Feb; 58(2):521-31. PubMed ID: 18240255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of immunosuppressants with bridge vasodilator therapy in severe lupus erythematosus-associated pulmonary arterial hypertension.
    Sanges S; Savale L; Lamblin N; Rémy-Jardin M; Humbert M; Sobanski V
    ESC Heart Fail; 2019 Dec; 6(6):1322-1325. PubMed ID: 31536678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe pulmonary arterial hypertension and massive ascites in a patient with systemic lupus erythematosus and secondary Sjogren's syndrome.
    Yucel H; Vollmer O; Canuet M; Enache I; Kessler R; Korganow AS; Riou M
    Lupus; 2021 Mar; 30(3):510-513. PubMed ID: 33655792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary hypertension in systemic lupus erythematosus: a report of three cases.
    Asherson RA; Hackett D; Gharavi AE; Harris EN; Kennedy HG; Hughes GR
    J Rheumatol; 1986 Apr; 13(2):416-20. PubMed ID: 3088276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corticosteroid pulse therapy in a patient with SLE and pulmonary hypertension.
    Kawaguchi Y; Hara M; Harigai M; Sakurada M; Nakamura H; Kashiwazaki S
    Clin Exp Rheumatol; 1998; 16(4):510. PubMed ID: 9706442
    [No Abstract]   [Full Text] [Related]  

  • 11. Pulmonary hypertension in systemic lupus erythematosus: evaluation of clinical characteristics and response to immunosuppressive treatment.
    Tanaka E; Harigai M; Tanaka M; Kawaguchi Y; Hara M; Kamatani N
    J Rheumatol; 2002 Feb; 29(2):282-7. PubMed ID: 11838845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary hypertension in systemic lupus erythematosus: effect of vasodilators on pulmonary hemodynamics.
    Mahowald ML; Weir EK; Ridley DJ; Messner RP
    J Rheumatol; 1985 Aug; 12(4):773-7. PubMed ID: 4057200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary arterial hypertension in systemic lupus erythematosus: current status and future direction.
    Dhala A
    Clin Dev Immunol; 2012; 2012():854941. PubMed ID: 22489252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary hypertension and systemic lupus erythematosus.
    Asherson RA; Oakley CM
    J Rheumatol; 1986 Feb; 13(1):1-5. PubMed ID: 2871187
    [No Abstract]   [Full Text] [Related]  

  • 15. Predictors of Favorable Responses to Immunosuppressive Treatment in Pulmonary Arterial Hypertension Associated With Connective Tissue Disease.
    Yasuoka H; Shirai Y; Tamura Y; Takeuchi T; Kuwana M
    Circ J; 2018 Jan; 82(2):546-554. PubMed ID: 28904255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary hypertension in systemic lupus erythematosus.
    Gladman DD; Sternberg L
    J Rheumatol; 1985 Apr; 12(2):365-7. PubMed ID: 4032410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic lupus erythematosus-associated pulmonary hypertension: good outcome following sildenafil therapy.
    Molina J; Lucero E; Luluaga S; Bellomio V; Spindler A; Berman A
    Lupus; 2003; 12(4):321-3. PubMed ID: 12729058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of pulmonary arterial hypertension.
    Huisman AM; Vreugdenhil SA; van Paassen HC
    N Engl J Med; 2005 Jan; 352(3):308-9; author reply 308-9. PubMed ID: 15659740
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of Vasodilator-resistant Mixed Connective Tissue Disease-associated Pulmonary Arterial Hypertension with Glucocorticoid and Cyclophosphamide.
    Sugawara E; Kato M; Hisada R; Oku K; Bohgaki T; Horita T; Yasuda S; Atsumi T
    Intern Med; 2017; 56(4):445-448. PubMed ID: 28202869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful use of intensive immunosuppressive therapy for treating simultaneously occurring cerebral lesions and pulmonary arterial hypertension in a patient with systemic lupus erythematosus.
    Watanabe R; Fujii H; Shirai T; Saito S; Hatakeyama A; Sugimura K; Fukumoto Y; Ishii T; Harigae H
    Intern Med; 2014; 53(6):627-31. PubMed ID: 24633036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.